Abstract
Immunological mechanisms play an important role in the pathogenesis of atherosclerosis and atherosclerotic abdominal aortic aneurysms (AAA). Inflammatory leukocytes invade the vessel wall and produce cytokines which perpetuate the immune events underlying these diseases. Interleukin (IL)-1β, IL-8, tumor necrosis factor-α, and monocyte chemoattractant protein-1, among others, may play a role in the generation by AAA. The aim of this study was to investigate the possible pathogenetic role of other proinflammatory cytokines, namely IL-2, IL-4, IL-6, and interferon (IFN)-gamma. Enzyme-linked immunosorbent assay of human explant culture supernatants revealed a significant increase in IFN-gamma production by AAAcompared to occlusive (atherosclerotic) or normal (NL) aortic explants. IL-6 production was also increased in AAA compared to NL aortic explant supernatants. Neither AAA nor NL aortic tissues produced IL-2 or IL-4 in the same culture system. These results suggest that IL-6, a cytokine involved in T and B lymphocyte activation during inflammation, and IFN-gamma, which stimulates T and B lymphocytes, macrophages, endothelial cells and fibroblasts, may play a role in the pathogenesis of various vascular inflammatory diseases such as AAA.
Similar content being viewed by others
References
A. E. Koch, G. K. Haines, R. J. Rizzo, J. A. Radosevich, R. M. Pope, P. G. Robinson and W. H. Pearce,Human abdominal aortic aneurysms: Immunophenotypic analysis suggesting an immune-mediated response. Am. J. Pathol.137, 1199–1213 (1990).
W. H. Pearce, A. Koch, G. K. Haines, C. Mesh, D. Parikh and J. S. T. Yao,Cellular components and immune response in abdominal aortic aneurysms. Surg. Forum13, 328–330 (1991).
W. H. Pearce, I. Sweis, J. S. T. Yao, W. J. McCarthy and A. E. Koch,Interleukin-1β and tumor necrosis factor-α release in normal and diseased human infrarenal aortas. J. Vasc. Surg.16, 784–789 (1992).
R. T. Rizzo, W. J. McCarthy, S. N. Dixit, M. P. Lilly, V. P. Shively, W. R. Flinn and J. S. T. Yao,Collagen types and matrix protein content in human abdominal aortic aneurysms. J. Vasc. Surg.10, 365–373 (1989).
A. E. Koch, S. L. Kunkel, W. H. Pearce, M. R. Shah, D. Parikh, H. L. Evanoff, G. K. Haines, M. D. Burdick and R. M. Strieter,Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms. Am. J. Pathol.142, 1423–1431 (1993).
E. E. Emeson and A. L. Robertson Jr,T lymphocytes in aortic and coronary intimas: Their potential role in atherogenesis. Am. J. Pathol.130, 369–376 (1988).
J. M. Munro, J. D. Van der Walt, C. S. Munro, J. A. C. Chalmers and E. L. Cox,An immunohistochemical analysis of human aortic fatty streaks. Hum. Pathol.18, 375–380 (1987).
G. K. Hansson, S. Jonasson, P. S. Seifert and S. Stemme,Immune mechanisms in atherosclerosis. Arteriosclerosis9, 567–578 (1989).
R. Ross,Mechanisms of atherosclerosis — A review. Adv. Nephrol.19, 79–86 (1990).
K. A. Smith,Interleukin 2. Annu. Rev. Immunol.2, 319–333 (1984).
M. H. Thornhill and D. O. Haskard DO,IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-gamma. J. Immunol.145, 865–872 (1990).
E. J. Kovacs,Fibrogenic cytokines: The role of immune mediators in the development of scar tissue. Immunol. Today12, 17–23 (1991).
P. C. Isakson,Antiimmunoglobulin-treated B cells respond to a B cell differentiation factor for IgG1. J. Exp. Med.164, 303–308 (1986).
P. E. Lipsky, L. S. Davis, J. J. Cush and N. Oppenheimer-Marks,The role of cytokines in the pathogenesis of rheumatoid arthritis. Springer Semin. Immunopathol.11, 123–162 (1989).
C. A. Feghali, K. L. Bost, D. W. Boulware and L. S. Levy,Mechanisms of pathogenesis in scleroderma. I. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with scleroderma. J. Rheumatol.19, 1207–1211 (1992).
J. S. Pober, M. A. Gimbrone Jr, L. A. Lapierre, D. L. Mendrick, W. Fiers, R. Rothlein and T. A. Springer,Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor and immune interferon. J. Immunol.137, 1893–1896 (1986).
M. L. Dustin, R. Rothlein, A. K. Bhan, C. A. Dinarello and T. A. Springer,Induction by IL-1 and interferon-gamma: Tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol.137, 245–254 (1986).
R. A. Swerlick, E. Garcia-Gonzalez, Y. Kubota, Y. L. Xu and T. J. Lawley,Studies of the modulation of MHC antigen and cell adhesion molecule expression on human dermal microvascular endothelial cells. J. Invest. Dermatol.97, 190–196 (1991).
J. F. Wedgwood, L. Hatam and V. R. Bonagura,Effect of interferon-gamma and tumor necrosis factor on the expression of class I and class II major histocompatibility molecules by cultured human umbilical vein endothelial cells. Cell. Immunol.111, 1–9 (1988).
H. Loppnow and P. Libby,Proliferating or interleukin-1 activated human vascular smooth muscle cells secrete copious interleukin 6. J. Clin. Invest.85, 731–738 (1990).
S. K. Clinton and P. Libby,Cytokines and growth factors in atherogenesis. Arch. Pathol. Lab. Med.116, 1292–1300 (1992).
C. M. Brophy, J. M. Reilly, G. J. Walker-Smith and M. D. Tilson,The role of inflammation in nonspecific abdominal aortic aneurysm disease. Ann. Vasc. Surg.5, 229–233 (1991).
B. W. Needleman, F. M. Wigley and R. W. Stair,Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma. Arth. Rheum.35, 67–72 (1992).
P. F. Zangerle, D. De Groote, M. Lopez, R. J. Meuleman, Y. Vrindts, F. Fauchet, I. Dehart, M. Jadoul, D. Radoux and P. Franchimont,Direct stimulation of cytokines (IL-1β, TNF-α IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood, II. Application to rheumatoid arthritis and osteoarthritis. Cytokine4, 568–575 (1992).
A. Ridderstad, M. Abedi-Valugerdi and E. Möller,Cytokines in rheumatoid arthritis. Ann. Med.23, 219–223 (1991).
R. Friesel, A. Komoriya and T. Maciag,Inhibition of endothelial cell prolioferation by gamma-interferon. J. Cell Biol.104, 689–696 (1987).
G. K. Hansson, J. Holm, L. Jonasson, M. M. Clowes and A. W. Clowes,Gamma-interferon regulates vascular smooth muscle cell proliferation and Ia expression in vivo and in vitro. Circ. Res.63, 712–719 (1988).
D. Y. Leung, T. Collins, L. A. Lapierre, R. S. Geha and J. S. Pober,Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. J. Clin. Invest.77, 1428–1435 (1986).
C. Y. Lin, C. C. Lin, B. Hwang and B. N. Chiang,Cytokines predict coronary aneurysm formation in Kawasaki disease patients. Eur. J. Pediatr.152, 309–312 (1993).
E. Chen, E. C. Keystone and E. N. Fish,Restricted cytokine expression in rheumatoid arthritis. Arth. Rheum.36, 901–910 (1993).
J. S. Pober and M. A. Gimbrone Jr.,Expression of Ia-like antigens by human vascular endothelial cells is inducible in vitro: Demonstration by monoclonal antibody binding and immunoprecipitation. Proc. Natl. Acad. Sci. USA79, 6641–6645 (1982).
M. Detmar, E. Imcke, Z. Ruszczak and C. E. Orfanos,Effects of recombinant tumor necrosis factor-alpha on cultured microvascular endothelial cells derived from human dermis. J. Invest. Dermatol.95, 219S-222S (1990).
A. C. van der Wal, P. K. Das, A. J. Tigges and A. E. Becker,Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am. J. Pathol.141, 1427–1433 (1992).
Q. B. Xu, G. Oberhuber, M. Gruschwitz and G. Wick,Immunology of atherosclerosis: Cellular composition and major histocompatability complex class II antigen expression in aortic intima, fatty streaks, and atherosclerotic plaques in young and aged human specimens. Clin. Immunol. Immunopathol.56, 344–359 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Szekanecz, Z., Shah, M.R., Pearce, W.H. et al. Human atherosclerotic abdominal aortic aneurysms produce interleukin (IL)-6 and interferon-gamma but not IL-2 and IL-4: The possible role for IL-6 and interferon-gamma in vascular inflammation. Agents and Actions 42, 159–162 (1994). https://doi.org/10.1007/BF01983484
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01983484